Literature DB >> 7818495

Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterization of naturally occurring hyaluronan-binding fragments of aggrecan.

V Vilim1, A J Fosang.   

Abstract

Proteoglycans extracted with 4 M guanidinium chloride from young (mean 20 years) or old (mean 79 years) macroscopically normal human articular cartilage were separated by density gradient centrifugation and Q-Sepharose chromatography and characterized by gradient gel SDS/PAGE and immunodetection before and after removal of glycosaminoglycan chains. The extracts contained two large populations of aggrecan, a population of small N-terminal aggrecan fragments, as well as decorin, biglycan and fibromodulin. The distribution of all these species in density gradient fractions has been determined. The large aggrecan populations comprised four different chondroitin sulphate-bearing core proteins while the population of smaller fragments comprised eight different components. The two smallest fragments (35 and 42 kDa), identified as the first globular domain of aggrecan (N-terminal) (G1) and containing no glycosaminoglycan, were detected only in extracts of old cartilage. A 55 and a 70 kDa fragment of G1 were present in both keratan sulphate-containing and non-keratan sulphate-containing forms. Four other fragments, each containing keratan sulphate epitopes, were identified and these contained either G1 epitopes (one 95 kDa species), or G1 and G2 epitopes (three species). These results have suggested that proteolytic processing at the N-terminus is more extensive than has previously been recognized and raises the possibility that more than one proteinase may be involved in aggrecan degradation in vivo. With the exception of the two smallest G1 fragments, the repertoire of proteoglycan fragments found in young and old human articular cartilage is essentially the same, although the relative abudnance of various species differed. The older tissue contains a larger proportion of C-terminally truncated aggrecan fragments and a significantly decreased content of decorin and biglycan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818495      PMCID: PMC1137416          DOI: 10.1042/bj3040887

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

Review 1.  Structure and biology of cartilage and bone matrix noncollagenous macromolecules.

Authors:  D Heinegård; A Oldberg
Journal:  FASEB J       Date:  1989-07       Impact factor: 5.191

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  The identification and characterization of two populations of aggregating proteoglycans of high buoyant density isolated from post-natal human articular cartilages of different ages.

Authors:  C Webber; T T Glant; P J Roughley; A R Poole
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

4.  Delayed aggregation of proteoglycans in adult human articular cartilage.

Authors:  M T Bayliss; G D Ridgway; S Y Ali
Journal:  Biosci Rep       Date:  1984-10       Impact factor: 3.840

5.  Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage.

Authors:  P J Roughley; R J White; A R Poole
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

6.  The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.

Authors:  L S Lohmander; P J Neame; J D Sandy
Journal:  Arthritis Rheum       Date:  1993-09

7.  The properties of proteoglycan prepared from human articular cartilage by using associative caesium chloride gradients of high and low starting densities.

Authors:  M T Bayliss; P J Roughley
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

8.  The synthesis of dermatan sulphate proteoglycans by fetal and adult human articular cartilage.

Authors:  L I Melching; P J Roughley
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

9.  Age-related changes in small proteoglycans of low buoyant density of human articular cartilage.

Authors:  V Stanescu; F Chaminade; M P Muriel
Journal:  Connect Tissue Res       Date:  1988       Impact factor: 3.417

10.  Structure of proteoglycans from different layers of human articular cartilage.

Authors:  M T Bayliss; M Venn; A Maroudas; S Y Ali
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

View more
  14 in total

1.  Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.

Authors:  Hidefumi Oshita; John D Sandy; Kiichi Suzuki; Atsushi Akaike; Yun Bai; Tomohiro Sasaki; Katsuji Shimizu
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

2.  The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1.

Authors:  J D Sandy; V Thompson; K Doege; C Verscharen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

3.  Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.

Authors:  J D Sandy; C Verscharen
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

4.  Aggrecan: A Target Molecule of Autoimmune Reactions.

Authors:  Edit I Buzás; Katalin Mikecz; Tibor T Glant
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

5.  Roles of aggrecan domains in biosynthesis, modification by glycosaminoglycans and product secretion.

Authors:  C Kiani; V Lee; L Cao; L Chen; Y Wu; Y Zhang; M E Adams; B B Yang
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

6.  Aggrecan degradation in human intervertebral disc and articular cartilage.

Authors:  R Sztrolovics; M Alini; P J Roughley; J S Mort
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

7.  Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.

Authors:  A J Fosang; K Last; R A Maciewicz
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

8.  Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.

Authors:  A J Fosang; K Last; P Gardiner; D C Jackson; L Brown
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

9.  Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

Authors:  G Perides; R A Asher; M W Lark; W S Lane; R A Robinson; A Bignami
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: implications for aggregate stability.

Authors:  M C Bolton; J Dudhia; M T Bayliss
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.